RLMD (Relmada) שולי הרווח הגולמי

The gross profit margin history demonstrates that Relmada Therapeutics (RLMD) is a company focused on the autonomous development of antidepressants prior to securing deals with industry behemoths. Strategic alliances with clinics accelerate the search for solutions for mental disorders. The application of NMDA receptor antagonists provides an immediate therapeutic effect. Meanwhile, the 0.00 level reflects the current amount of profit after deducting production costs, helping to avoid emotional errors when investing.
פילוחי מדדים פיננסיים ומדדי שוק עבור Relmada Therapeutics Inc (RLMD)

Gross margin measures production efficiency by determining the portion of revenue remaining after covering direct operating costs associated with product creation. By analyzing the gross profit margin on GURU.Markets, an investor assesses the ability of Relmada Therapeutics (RLMD) to monetize the intellectual capital of elite neurologists, whose developments in depression therapy are expected to transform into high-margin drugs with minimal cost of goods sold.